First Page | Document Content | |
---|---|---|
Date: 2016-08-24 06:15:45Medicine Pulmonology Clinical medicine Respiratory therapy Pulmonary function testing Respiratory physiology Chronic lower respiratory diseases Respimat Thiophenes Tiotropium bromide Bronchodilator Beta2-adrenergic agonist | Microsoft WordSpiriva final redline new IFU.docxAdd to Reading ListSource URL: docs.boehringer-ingelheim.comDownload Document from Source WebsiteFile Size: 501,59 KBShare Document on Facebook |
Microsoft WordSpiriva final redline new IFU.docxDocID: 1rn7z - View Document | |
COPD Care Map for Primary Care Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________DocID: 1qO6l - View Document | |
Spiriva® Powder for Inhalation (in Capsule) Tiotropium bromide Consumer Medicine InformationDocID: 1fwRM - View Document | |
BMJ 2011;342:d2970 doi: bmj.d2970 Page 1 of 2 EditorialsDocID: 1aKAn - View Document | |
KEY ASPECTS 2014 Andreas Barner, Wolfgang Baiker, Allan Hillgrove, Joachim Hasenmaier, Hubertus von Baumbach (from left to right), the Board of Managing Directors KEY ASPECTS 2014DocID: 1atQi - View Document |